Cytodiagnostics is a biotechnology company based in Burlington, Ontario, Canada. We focus on providing and developing nanotechnology derived products and services for the international life science...
Colloidal gold has found use as a key constituent in several biomedical applications, ranging from catalysis and diagnostic assays to in-vivo tumour targeting.
http://www.azonano.com/article.aspx?ArticleID=3811 | 27 Feb 2014
Cytodiagnostics applies unique proprietary protocols for producing spherical and non-spherical gold nanoparticles, yielding homogeneously shaped nanoparticles with a narrow size distribution.
http://www.azonano.com/article.aspx?ArticleID=3810 | 27 Feb 2014
Gold nanoparticle conjugates have found use in a variety of biological applications including, the role as probes in light and electron microscopy.
http://www.azonano.com/article.aspx?ArticleID=3812 | 27 Feb 2014
The potential for nanoparticles to be used in biological, chemical, and industrial areas is infinite. Researchers are working on new applications constantly.
http://www.azonano.com/article.aspx?ArticleID=3337 | 8 Apr 2013
Gold nanoparticles have been used in many applications in medicine and biology, including as optical contrast agents, drug delivery vehicles, cellular probes, and biosenors.
http://www.azonano.com/article.aspx?ArticleID=3813 | 27 Feb 2014
The NHS-activated Gold Nanoparticle Conjugation Kits offered by Cytodiagnostics have been designed for high-efficiency, single-step conjugations of proteins and other primary amine-containing ligands...
http://www.azonano.com/article.aspx?ArticleID=3809 | 27 Feb 2014
Global gold nanoparticles market is expected to reach USD 4.86 billion by 2020, according to a new study by Grand View Research, Inc. Medical & dentistry was the largest end-use segment for the...
http://www.azonano.com/news.aspx?newsID=31959 | 28 Jan 2015